Relapsed/Refractory Multiple Myeloma: Hematology Journal Club
This journal club was a scientific-educational activity discussing on the convenient treatment protocols for the management of relapsed/ refractory Multiple Myeloma patients and sharing data of Carfilzomib from Moreau et al. 2018 A.R.R.O.W. Trial.
Speaker: Arif Alam
Affiliations: Division Chief of Hematology Clinic, Tawam Hospital, United Arab Emirates
This presentation was part of a scientific educational activity discussing on the convenient treatment protocols for the management of relapsed/ refractory Multiple Myeloma patients and sharing data of Carfilzomib from Moreau et al. 2018 A.R.R.O.W. Trial.
Speaker: Hassan Yassin
Affiliations: Internist and Clinical Hematologist, Rashid Hospital, United Arab Emirates
This presentation was part of a scientific educational activity discussing on the convenient treatment protocols for the management of relapsed/ refractory Multiple Myeloma patients and sharing data of Carfilzomib from Moreau et al. 2018A.R.R.O.W. Trial
Speaker: Dr. Amar Lal
Affiliations: Consultant Hematologist, Tawam Hospital, Al Ain, United Arab Emirates
This topic was presented during the Emirates Society of Haematology virtual educational series hosted in 2021.
Panel Discussion including Dr. Amar Lal, Dr. Faraz Khan, Dr. Hassan Yassin, and Dr. Arif Alam.